Decades of effort including the development of guidance and implementation by individuals, groups, professional organizations, even the United States Congress, to address and facilitate inclusion of pregnant and lactating people in research and trials held no sway in the studies addressing the coronavirus disease 2019 (COVID-2019) pandemic.
"An inclusion mandate should be required for pregnant and lactating people in research. At present, pregnant people are excluded from research by default. Those governing, funding, and/or mandating trials should require an explanation of why pregnant and lactating people are excluded," Catherine Y. Spong, MD wrote in her March editorial for Contemporary OB/GYN®.
Do you agree that further expansion to include pregnant and lactating people is an attainable short-term goal?
"The 2000 U.S. Government Accountability Office Report on Women’s Health found significant progress in the representation of women in clinical trials because of the requirement of assessment of their inclusion as part of the scientific merit of the research grant. In the past several decades this has expanded and now all NIH grant applications include a section on inclusion on the basis of sex/gender, race, ethnicity, and age in clinical research. Further expansion to include pregnant and lactating people is an attainable short-term goal that will focus the inclusion by default," Spong wrote.
We want to hear from you. Do you agree with Spong, that expansion to include pregnant and lactating people is an attainable, short-term goal?
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More